Related Experiment Video
Updated: Apr 15, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.8K
Chronic bronchitis leads to accelerated hyperinflation in COPD patients during exercise
Wen Zhang1, Haitao Lu, Liyue Peng
1Department of Pulmonary and Critical Care Medicine, Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Respirology (Carlton, Vic.)
|March 25, 2015
Summary
Chronic bronchitis (CB) significantly reduces exercise capacity in patients with chronic obstructive pulmonary disease (COPD). This is due to dynamic hyperinflation during exercise, potentially increasing inflammation.
Area of Science:
- Pulmonary Medicine
- Exercise Physiology
Background:
- Chronic obstructive pulmonary disease (COPD) is a major health concern.
- The impact of chronic bronchitis (CB) on exercise capacity in COPD patients remains unclear.
Purpose of the Study:
- To investigate exercise capacity differences in COPD patients with and without chronic bronchitis (CB).
- To identify factors associated with peak oxygen consumption (V̇O₂) in COPD patients.
Main Methods:
- Spirometry, 6-minute walk distance, and cardiopulmonary exercise testing were performed.
- Participants included healthy controls, COPD patients without CB, and COPD patients with CB.
- Multiple regression analysis identified predictors of peak V̇O₂.
Main Results:
- COPD patients with CB (CB(+)) exhibited lower peak oxygen consumption (V̇O₂) compared to those without CB (CB(-)).
- CB(+) patients showed increased respiratory rate (RR) and earlier dynamic hyperinflation during exercise.
- Chronic bronchitis, FEV1, diffusing capacity, RV/TLC ratio, and TNF-α predicted peak V̇O₂.
Conclusions:
- Chronic bronchitis significantly impairs exercise capacity in COPD patients due to dynamic hyperinflation.
- Accelerated dynamic hyperinflation in CB(+) COPD patients may exacerbate airway and systemic inflammation.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.2K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K